Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Lymph node ratio should be considered for incorporation into staging for breast cancer.

Chagpar AB, Camp RL, Rimm DL.

Ann Surg Oncol. 2011 Oct;18(11):3143-8. doi: 10.1245/s10434-011-2012-9. Epub 2011 Aug 17.

PMID:
21847696
2.

Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients.

Schiffman SC, McMasters KM, Scoggins CR, Martin RC, Chagpar AB.

J Am Coll Surg. 2011 Jul;213(1):45-52; discussion 52-3. doi: 10.1016/j.jamcollsurg.2011.04.024. Epub 2011 May 20.

PMID:
21601490
3.

Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.

Ahn SH, Kim HJ, Lee JW, Gong GY, Noh DY, Yang JH, Jung SS, Park HY.

Breast Cancer Res Treat. 2011 Nov;130(2):507-15. doi: 10.1007/s10549-011-1730-9. Epub 2011 Aug 21.

PMID:
21858659
4.

Lymph node ratio as an alternative to pN staging in node-positive breast cancer.

Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G, Deglise C, Usel M, Lutz JM, Bouchardy C.

J Clin Oncol. 2009 Mar 1;27(7):1062-8. doi: 10.1200/JCO.2008.18.6965. Epub 2009 Jan 21.

PMID:
19164210
5.

Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer.

Wang F, He W, Qiu H, Wang X, Guo G, Chen X, Rong Y, Zhou F, Yin C, Yuan Z, Xia L.

Clin Breast Cancer. 2012 Dec;12(6):404-11. doi: 10.1016/j.clbc.2012.07.009. Epub 2012 Sep 29.

PMID:
23026023
6.

Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series.

Truong PT, Lesperance M, Li KH, MacFarlane R, Speers CH, Chia S.

Ann Surg Oncol. 2010 Aug;17(8):2138-46. doi: 10.1245/s10434-010-0954-y. Epub 2010 Feb 12.

PMID:
20151215
7.

Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients?

Saxena N, Hartman M, Yip CH, Bhoo-Pathy N, Khin LW, Taib NA, Looi LM, Lim SE, Lee SC, Verkooijen HM.

PLoS One. 2012;7(9):e45809. doi: 10.1371/journal.pone.0045809. Epub 2012 Sep 24.

8.

Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients.

Yang C, Liu F, Li S, Li W, Zhai L, Ren M, Li Y, Lang R, Fan Y, Zhang X, Fu L.

Int J Surg Pathol. 2012 Dec;20(6):546-54. doi: 10.1177/1066896912451323. Epub 2012 Jun 25.

PMID:
22736300
9.

The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study.

Dings PJ, Elferink MA, Strobbe LJ, de Wilt JH.

Ann Surg Oncol. 2013 Aug;20(8):2607-14. doi: 10.1245/s10434-013-2932-7. Epub 2013 Mar 28.

PMID:
23536053
10.

The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.

Solak M, Turkoz FP, Keskin O, Aksoy S, Babacan T, Sarici F, Kertmen N, Sever AR, Altundag K.

J BUON. 2015 May-Jun;20(3):737-45.

PMID:
26214625
11.

The number of lymph nodes dissected in breast cancer patients influences the accuracy of prognosis.

Wiznia LE, Lannin DR, Evans SB, Hofstatter EW, Horowitz NR, Killelea BK, Tsangaris TN, Chagpar AB.

Ann Surg Oncol. 2014 Feb;21(2):389-94. doi: 10.1245/s10434-013-3308-8. Epub 2013 Oct 17.

PMID:
24132625
12.

Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.

Chen S, Liu Y, Huang L, Chen CM, Wu J, Shao ZM.

Ann Surg Oncol. 2014 Jan;21(1):42-50. doi: 10.1245/s10434-013-3245-6. Epub 2013 Sep 7.

PMID:
24013900
13.

Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).

Tausch C, Taucher S, Dubsky P, Seifert M, Reitsamer R, Kwasny W, Jakesz R, Fitzal F, Filipcic L, Fridrik M, Greil R, Gnant M.

Ann Surg Oncol. 2012 Jun;19(6):1808-17. doi: 10.1245/s10434-011-2189-y. Epub 2011 Dec 30.

PMID:
22207051
14.

Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.

Wang CL, Li Y, Yue DS, Zhang LM, Zhang ZF, Sun BS.

World J Surg. 2012 Feb;36(2):455-62. doi: 10.1007/s00268-011-1360-8.

PMID:
22187129
15.

Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.

Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J, Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K, Shamseddine AI.

Ann Surg Oncol. 2009 Dec;16(12):3388-95. doi: 10.1245/s10434-009-0653-8.

PMID:
19655200
16.

[Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].

Li Y, Sun BS, Zhang ZF, Zhang LM, Wang CL.

Zhonghua Yi Xue Za Zhi. 2011 Jun 28;91(24):1682-6. Chinese.

PMID:
21914316
17.

Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia.

Ibrahim EM, Elkhodary TR, Zekri JM, Bahadur Y, El-Sayed ME, Al-Gahmi AM, Rizvi SA, Hassouna AH, Fawzy EE, Awadalla SS.

Asia Pac J Clin Oncol. 2010 Jun;6(2):130-7. doi: 10.1111/j.1743-7563.2010.01288.x.

PMID:
20565426
18.
19.

[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].

Guan Y, Xu BH, Li Q, Zhang P, Zhao LM, Yuan P, Wang JY.

Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):77-81. Chinese.

PMID:
18353207
20.

Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes.

Shirai Y, Sakata J, Wakai T, Ohashi T, Ajioka Y, Hatakeyama K.

World J Surg Oncol. 2012 May 17;10:87. doi: 10.1186/1477-7819-10-87.

Supplemental Content

Support Center